Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion

D Simancas‐Racines, D Osorio… - Cochrane Database …, 2015 - cochranelibrary.com
Background A blood transfusion is an acute intervention, implemented to solve life and
health‐threatening conditions on a short‐term basis. However, blood transfusions have …

Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products

CA Ludlam, ML Turner - British journal of haematology, 2006 - Wiley Online Library
Whereas plasma‐derived clotting factor concentrates now have a very good safety record for
not being infectious for lipid enveloped viruses, concern has arisen about the possibility that …

Transfusion transmission of human prion diseases

S Zou, CT Fang, LB Schonberger - Transfusion medicine reviews, 2008 - Elsevier
No transmission through transfusion has been reported for classic Creutzfeldt-Jakob
disease (CJD). Moreover, a series of epidemiological surveillance, case-control, and look …

Modeling red cell procurement with both double‐red‐cell and whole‐blood collection and the impact of European travel deferral on units available for transfusion

E Madden, EL Murphy, B Custer - Transfusion, 2007 - Wiley Online Library
BACKGROUND: In 1997 the FDA approved the first double‐red‐blood‐cell (2RBC)
collection device. Soon after, travel deferral for variant Creutzfeldt‐Jakob disease (vCJD) …

Tissue safety in view of CJD and variant CJD

G Pauli - Cell and tissue banking, 2005 - Springer
Epidemiological studies on human transmissible spongiform encephalopathies (Creutzfeldt–
Jakob Disease, CJD) have shown that the agent could be transmitted by highly infectious …

Notification and support for people exposed to the risk of Creutzfeldt‐Jakob disease (CJD)(or other prion diseases) through medical treatment (iatrogenically)

R Ryan, S Hill, D Lowe, K Allen… - … of systematic reviews, 2011 - cochranelibrary.com
Background Creutzfeldt‐Jakob disease (CJD) and variant CJD (vCJD) are rare and always‐
fatal diseases transmissible via certain medical procedures. If a person is exposed to the …

Expert judgement and re-elicitation for prion disease risk uncertainties

MG Tyshenko, S ElSaadany, T Oraby… - … Journal of Risk …, 2012 - inderscienceonline.com
Much uncertainty surrounds transmission of transmissible spongiform encephalopathies
(TSEs) through blood and blood derived products. A first expert elicitation with 14 experts …

Perioperative transfusion of leukocyte-depleted blood products in contemporary radical cystectomy cohort does not adversely impact short-term survival

JJ Chipollini, DH Tang, SY Patel, RE Garcia-Getting… - Urology, 2017 - Elsevier
Objective To evaluate the effect of leukoreduced-only perioperative blood transfusion (PBT)
and corresponding survival outcomes in a radical cystectomy cohort of patients. Materials …

Safety of blood, blood derivatives, and plasma-derived products

ML Turner - Handbook of Clinical Neurology, 2018 - Elsevier
There has been concern for several decades around the possibility that prion diseases may
be transmissible by blood components and/or plasma products. Whilst the evidence in …

Ethical considerations in presymptomatic testing for variant CJD

RE Duncan, MB Delatycki, SJ Collins, A Boyd… - Journal of medical …, 2005 - jme.bmj.com
Variant Creutzfeldt–Jakob disease (vCJD) is a fatal, transmissible, neurodegenerative
disorder for which there is currently no effective treatment. vCJD arose from the zoonotic …